Positron emission tomography evaluation of sedative properties of antihistamines

Bibliography

• Watanabe T, Yanai K. Studies on functional roles of the histaminergic neuron system by using pharmacological agents, knockout mice and positron emission tomography. Tohoku J Exp Med 2001;195:197-217
   PubMed Web of Science ®Google Scholar
• Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev 2008;88:1183-241
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Funahashi J, Mori K, The noncompetitive antagonism of histamine H1 receptors expressed in Chinese hamster ovary cells by olopatadine hydrochloride: its potency and molecular mechanism. Pharmacology 2008;81:266-74
   PubMed Web of Science ®Google Scholar
• Gillard M, Van Der Perren C, Moguilevsky N, Binding characteristics of cetirizine and levocetirizine to human H1 histamine receptors: contribution of Lys(191) and Thr(194). Mol Pharmacol 2002;61:391-9
   PubMed Web of Science ®Google Scholar
• Kato M, Nishida A, Aga Y, Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate. Arzneimittelforschung 1997;47:1116-24
   PubMed Web of Science ®Google Scholar
• Yanai K, Tashiro M. The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies. Pharmacol Ther 2007;113:1-15
   PubMed Web of Science ®Google Scholar
• Weiler JM, Bloomfield JR, Woodworth GG, Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med 2000;132:354-63
   PubMed Web of Science ®Google Scholar
• Vuurman EF, van Veggel LM, Uiterwijk MM, Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993;71:121-6
   PubMedGoogle Scholar
• Boyle J, Eriksson M, Stanley N, Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects. Curr Med Res Opin 2006;22:1343-51
   PubMed Web of Science ®Google Scholar
• Okamura N, Yanai K, Higuchi M, Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine. Br J Pharmacol 2000;129:115-23
   PubMed Web of Science ®Google Scholar
• Tagawa M, Kano M, Okamura N, Differential cognitive effects of ebastine and d-chlorpheniramine in healthy subjects. Br J Clin Pharmacol 2002;53:296-304
   PubMed Web of Science ®Google Scholar
• Mochizuki H, Tashiro M, Tagawa M, The effects of a sedative antihistamine, d-chlorpheniramine, on visuomotor spatial discrimination and regional brain activity as measured by positron emission tomography (PET). Hum Psychopharmacol 2002;17:413-18
   PubMed Web of Science ®Google Scholar
• Tashiro M, Horikawa E, Mochizuki H, Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use. Hum Psychopharmacol 2005;20:501-9
   PubMed Web of Science ®Google Scholar
• Holgate ST, Canonica GW, Simons F, Consensus group on new-generation antihistamines (CONGA): present status and recommendations. Clin Exp Allergy 2003;33:1305-24
   PubMed Web of Science ®Google Scholar
• Yanai K, Yagi N, Watanabe T, Specific binding of [3H]pyrilamine to histamine H1 receptors in guinea pig brain in vivo: determination of binding parameters by a kinetic four-compartment model. J Neurochem 1990;55:409-20
   PubMed Web of Science ®Google Scholar
• Yanai K, Watanabe T, Yokoyama H, Histamine H1 receptors in human brain visualized in vivo by [11C]doxepin and positron emission tomography. Neurosci Lett 1992;137:145-8
   PubMed Web of Science ®Google Scholar
• Yanai K, Ryu JH, Watanabe T, Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography. Br J Pharmacol 1995;116:1649-55
   PubMed Web of Science ®Google Scholar
• Yanai K, Okamura N, Tagawa M, New findings in pharmacological effects induced by antihistamines: from PET studies to knock-out mice. Clin Exp Allergy 1999;29(Suppl 3):29-36
   PubMedGoogle Scholar
• Tagawa M, Kano M, Okamura N, Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine. Br J Clin Pharmacol 2001;52:501-9
   PubMed Web of Science ®Google Scholar
• Tashiro M, Sakurada Y, Iwabuchi K, Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using [11C] doxepin positron emission tomography. J Clin Pharmacol 2004;44:890-900
   PubMed Web of Science ®Google Scholar
• Tashiro M, Mochizuki H, Sakurada Y, Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with [11C] doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen. Br J Clin Pharmacol 2006;61:16-26
   PubMed Web of Science ®Google Scholar
• Tashiro M, Duan X, Kato M, Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with [11C]doxepin. Br J Clin Pharmacol 2008;65:811-21
   PubMed Web of Science ®Google Scholar
• Tashiro M, Kato M, Miyake M, Dose dependency of brain histamine H1 receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11C]doxepin. Hum Psychopharmacol 2009;24:540-8
   PubMed Web of Science ®Google Scholar
• Mochizuki H, Kimura Y, Ishii K, Quantitative measurement of histamine H1 receptors in human brains by PET and [11C]doxepin. Nucl Med Biol 2004;31:165-71
   PubMed Web of Science ®Google Scholar
• Mochizuki H, Kimura Y, Ishii K, Simplified PET measurement for evaluating histamine H1 receptors in human brains using [11C]doxepin. Nucl Med Biol 2004;31:1005-11
   PubMed Web of Science ®Google Scholar
• Suzuki A, Tashiro M, Kimura Y, Use of reference tissue models for quantification of histamine H1 receptors in human brain by using positron emission tomography and [11C]doxepin. Ann Nucl Med 2005;19:425-33
   PubMed Web of Science ®Google Scholar
• Shamsi Z, Hindmarch I. Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol 2000;15(S1):S3-S30
   PubMedGoogle Scholar
• McDonald K, Trick L, Boyle J. Sedation and antihistamines: an update. Review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol 2008;23:555-70
   PubMed Web of Science ®Google Scholar
• Plaut M, Valentine MD. Clinical practice. Allergic rhinitis. N Engl J Med 2005;353:1934-44
   PubMed Web of Science ®Google Scholar
• Zuberbier T, Asero R, Bindslev-Jensen C, EAACI/GA2LEN/EDF/WAO guideline: management of Urticaria. Allergy 2009;64:1427-43
   PubMed Web of Science ®Google Scholar
• Church MK, Maurer M, Simons FER, Risk of first-generation H1-antihistamines: a GA2LEN position paper. Allergy 2010;65:459-66
   PubMed Web of Science ®Google Scholar
• Senda M, Kubo N, Adachi K, Potential measured with PET under a test dose of olopatadine, an antihistamine, is reduced after repeated administration of olopatadine. J Nucl Med 2009;50:887-92
   PubMed Web of Science ®Google Scholar
• Zhang D, Tashiro M, Shibuya K, Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography. J Clin Psychopharmacol 2010;30:694-701
   PubMed Web of Science ®Google Scholar
• Boyle J, Eriksson M, Stanley N, Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects. Curr Med Res Opin 2006;22:1343-51
   PubMed Web of Science ®Google Scholar